Patients receiving long-term hemodialysis (HD) treatment are more susceptible to infections, leading to a higher likelihood of mortality and morbidity (
1,
2). Sepsis is the second most common cause of death in individuals on chronic HD following cardiovascular events (
3). Catheter-related infections are the most common causes of bacteremia in patients undergoing HD (
4). Risk factors for infection emergence in various studies include patient age, duration of access, presence of underlying diseases such as diabetes mellitus and an immune-compromised state, catheter insertion site, type of access, history of previous access-related infection, and nasal colonization with
Staphylococcus aureus (
S. aureus) (
5-
7). Hypoalbuminemia has been described as one of the risk factors with an increased risk of bacteremia, infection, and worse prognosis in HD patients. (
5,
8,
9). Short-term mortality and hospitalization are three times higher in patients with low serum albumin levels than those with normal serum albumin levels (
10). There are various mechanisms by which HD patients develop hypoalbuminemia: Decreased protein synthesis due to malnutrition, changes in the volume of distribution, loss of protein during dialysis, which is common in patients on intermittent HD, and decreased synthesis of anabolic hormones, which are involved in albumin production, such as thyroid hormones and cortisol. On the other hand, albumin is also considered a negative acute phase protein, and its synthesis is reduced in acute conditions and inflammation (
11).